Company intelligence / Profile preview

InSeal Medical

Caesarea/Qesarya, Haifa District, Israelfinder.startupnationcentral.org ↗

Ownership: Private
Development stage: Other

Overview

The company’s lead product, the InClosure VCD, has demonstrated successful acute sealing and hemostasis in clinical studies for large-bore arterial punctures during TAVR and EVAR procedures. CE Mark approval was granted based on positive clinical results showing fast deployment (<2 minutes), reliable vessel closure without pre-procedure manipulation, and favorable patient recovery profiles with no major complications reported through at least 30 days follow-up.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Polaris Venture Partners (investor/backer)

Beyond the preview

Go deeper on InSeal Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InSeal Medical.

Explore the full profile